- Home
- NEWT vs LXEO Comparison
NEWT vs LXEO Comparison
Compare NEWT & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWT
- LXEO
- Stock Information
- Founded
- NEWT 1998
- LXEO 2017
- Country
- NEWT United States
- LXEO United States
- Employees
- NEWT N/A
- LXEO N/A
- Industry
- NEWT Major Banks
- LXEO
- Sector
- NEWT Finance
- LXEO
- Exchange
- NEWT Nasdaq
- LXEO Nasdaq
- Market Cap
- NEWT 342.5M
- LXEO 286.3M
- IPO Year
- NEWT N/A
- LXEO 2023
- Fundamental
- Price
- NEWT $13.74
- LXEO $9.10
- Analyst Decision
- NEWT Hold
- LXEO Strong Buy
- Analyst Count
- NEWT 3
- LXEO 7
- Target Price
- NEWT $12.33
- LXEO $22.14
- AVG Volume (30 Days)
- NEWT 155.8K
- LXEO 380.0K
- Earning Date
- NEWT 11-06-2024
- LXEO 11-21-2024
- Dividend Yield
- NEWT 5.55%
- LXEO N/A
- EPS Growth
- NEWT 18.20
- LXEO N/A
- EPS
- NEWT 1.66
- LXEO N/A
- Revenue
- NEWT $301,043,000.00
- LXEO N/A
- Revenue This Year
- NEWT N/A
- LXEO N/A
- Revenue Next Year
- NEWT $6.30
- LXEO N/A
- P/E Ratio
- NEWT $8.24
- LXEO N/A
- Revenue Growth
- NEWT 54.13
- LXEO N/A
- 52 Week Low
- NEWT $10.07
- LXEO $7.86
- 52 Week High
- NEWT $15.75
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- NEWT 71.38
- LXEO 48.00
- Support Level
- NEWT $12.34
- LXEO $7.88
- Resistance Level
- NEWT $12.47
- LXEO $8.96
- Average True Range (ATR)
- NEWT 0.33
- LXEO 0.52
- MACD
- NEWT 0.15
- LXEO 0.15
- Stochastic Oscillator
- NEWT 100.00
- LXEO 82.67
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.